This HTML5 document contains 54 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q68778289
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu n'ochobre de 1987 im Oktober 1987 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в жовтні 1987 wetenschappelijk artikel scientific article published on 01 October 1987
p:P577
wds:Q68778289-730DB6A5-8C74-4498-84EB-875CB68A1219
wdt:P577
1987-10-01T00:00:00Z
p:P2093
wds:Q68778289-FFEE78B5-94C9-4FC7-8870-ECE3C5F80A1E wds:Q68778289-CD0B9C88-FAD3-404A-88A3-004738D66995 wds:Q68778289-CC9D9E25-63BF-42C2-A945-7A5466D90CF2 wds:Q68778289-567F02D4-84F6-4CDF-BC5B-D2CC44FE9C58 wds:Q68778289-5A078723-4CE0-4BFC-9884-0EBF42B039A7 wds:Q68778289-4FA61937-E227-4112-8E35-9F67E91D6E34 wds:Q68778289-AEB3E3E8-8C57-4779-B886-5FE4A21C1A91 wds:Q68778289-AE7D0449-E655-4E28-AA9B-89736418F972 wds:Q68778289-7B157308-9DFB-4B53-887C-E69262995088
wdt:P2093
R Somers H M Pinedo D Thomas A T van Oosterom A Santoro V Bramwell H T Mouridsen J H Mulder J Buesa
rdfs:label
Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group
skos:prefLabel
Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group
schema:name
Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group
p:P50
wds:Q68778289-B93CBF77-E40C-424E-87FC-BFD33793EBF5
wdt:P50
wd:Q56849196
p:P1476
wds:Q68778289-2AEBB1E4-7068-46E4-8E39-1F596D1789E4
wdt:P1476
Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group
p:P304
wds:Q68778289-6BA88B0E-0E5E-44EA-8EAC-297F146E2A42
wdt:P304
1477-1483
p:P31
wds:Q68778289-E5906A80-A916-42DB-ACD3-804DFB843A8A
wdt:P31
wd:Q13442814
p:P921
wds:Q68778289-C7EB68F4-A4F3-449A-8F91-E2098F22E865
wdt:P921
wd:Q18936
p:P698
wds:Q68778289-517DDFDF-806B-4F3F-A332-BC1A5716BBE1
wdtn:P698
n12:3479329
wdt:P698
3479329
p:P1433
wds:Q68778289-232B1E3C-12A9-4A34-A966-6AE2F3C9539D
wdt:P1433
wd:Q27710832
p:P433
wds:Q68778289-A1830A72-8D80-4CB9-AC31-5186BB53F3A8
p:P478
wds:Q68778289-A14D5B8C-9360-46ED-9745-B38162E50715
wdt:P433
10
wdt:P478
23
p:P356
wds:Q68778289-0F31F32A-7173-468A-9F2E-F0B70E3528DB
wdtn:P356
n9:0277-5379(87)90089-7
wdt:P356
10.1016/0277-5379(87)90089-7